New drug trial seeks to control aggressive blood cancers
Disease control
Terminated
This study is testing an intravenous drug called brincidofovir in people whose lymphoma has come back or hasn't responded to previous chemotherapy. The main goals are to find a safe dose and see if the drug can help shrink tumors. The trial is currently suspended and was planned …
Phase: PHASE1, PHASE2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC